Naxim (Ambroxol Hydrochloride)

Ambroxol stimulates surfactant production by type II pneumocytes and reduces the viscosity of mucus through activation of serine proteases. This dual action improves mucociliary clearance, allowing thicker secretions to be thinned and expectorated more effectively.

The appropriate dose of Naxim is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and route of administration. Dosage instructions should always follow the prescriber’s recommendation and the product label.

Safety data for ambroxol hydrochloride in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Naxim to pregnant or breastfeeding women. The decision should be made on an individual basis.

To order Naxim, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other mucolytics such as acetylcysteine, ambroxol (Naxim) not only reduces mucus viscosity but also stimulates surfactant production, which may enhance cough effectiveness. The choice of agent depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Naxim should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain its stability and potency throughout its shelf life.

Naxim can be administered orally as a tablet or syrup, and in some formulations may be delivered by inhalation. The exact route and method of administration are determined by the prescriber according to the patient’s condition and the product’s dosage form.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant hepatic enzyme elevations. Patients should be instructed to seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or jaundice.

Naxim should not be used by individuals with known hypersensitivity to ambroxol hydrochloride or any of the product’s excipients. Caution is also advised for patients with severe renal impairment, uncontrolled asthma, or those taking contraindicated medications listed under major interactions.